Form 4: Axogen Director Gregory Freitag Sells 25,000 Shares
SEC Form 4 Filing
Gregory Freitag, a director at Axogen, Inc., sold 25,000 shares of common stock at an average price of $9 per share on March 7, 2024.
Summary
- On March 7, 2024, Gregory Freitag, a director of Axogen, Inc., sold 25,000 shares of the company's common stock.
- The sale was executed at a weighted average price of $9 per share, with individual transactions ranging from $8.95 to $9.00.
- Following the transaction, Freitag directly owns 271,594 shares of Axogen common stock.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing a stock sale. It doesn't inherently convey positive or negative sentiment.
Industry Context
Sales by company directors are a normal part of market activity. It is difficult to assess the impact of this sale without more context.
Stakeholder Impact
- The sale of shares by a director could potentially influence investor sentiment, although the impact is likely to be minimal given the size of the transaction relative to the company's overall market capitalization.
Key Dates
| Date | Description |
|---|---|
| 03/07/2024 | Date of the transaction: Gregory Freitag sold 25,000 shares of Axogen common stock. |
| 03/08/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.